Abreu out of lineup again as White Sox open road series against Rangers

SHARE Abreu out of lineup again as White Sox open road series against Rangers

ARLINGTON, Texas — First baseman Jose Abreu will miss his third consecutive start for the White Sox Tuesday because of inflammation in his right index finger.

Abreu missed Saturday’s and Sunday’s games in Houston, and after an off day Monday for the team, was hopeful of returning Tuesday. Adam LaRoche will start in his place at first base and Conor Gillaspie will be the designated hitter. Manager Robin Ventura said a Wednesday return is possible.

“He is getting better,” Ventura said. “You could send him out there and one swing could probably send him back five more days. It’s gotten a lot better than it was in Houston, it’s just not to a point where I’m comfortable having him go out there and swing full-time in a game.”

Here’s what general manager Rick Hahn had to say about Abreu:

The Sox are 4-4 on their current 11-game road trip. They finished the month of May with a 15-15 record and are 23-26 and in last place in the American League Central.

Here is how the Sox line up Tuesday against Rangers right-hander Colby Lewis:

Adam Eaton cf

Melky Cabrera lf

Adam LaRoche 1b

Avisail Garcia rf

Conor Gillaspie dh

Alexei Ramirez ss

Gordon Beckham 3b

Geovany Soto c

Jeff Samardzija p (4-2, 3.84)

The Latest
Sabrina Ionescu and Natasha Howard each had 22 points while Betnijah Laney added 17 points, five rebounds and five assists
The Chicago Park District should focus instead on upgrading Jackson Park and South Shore courses.
The program mentors young adults dealing with gun violence and helps them get their GEDs. They want to show them “you’re worthy, you’re valid, and this is only one of the many things that you will go on to accomplish,” a CRED employee said.
The four boys were on the front porch of a residence in the 7300 block of South Union Avenue when someone fired shots, police said.
The district and teachers’ union have negotiated all summer in hopes of avoiding the contentious battles of the past two years over pandemic safety.